- Home
- QMCO vs TCRX Comparison
QMCO vs TCRX Comparison
Compare QMCO & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- TCRX
- Stock Information
- Founded
- QMCO 1980
- TCRX 2018
- Country
- QMCO United States
- TCRX United States
- Employees
- QMCO N/A
- TCRX N/A
- Industry
- QMCO Electronic Components
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- QMCO Technology
- TCRX Health Care
- Exchange
- QMCO Nasdaq
- TCRX Nasdaq
- Market Cap
- QMCO 80.0M
- TCRX 90.5M
- IPO Year
- QMCO N/A
- TCRX 2021
- Fundamental
- Price
- QMCO $11.50
- TCRX $1.46
- Analyst Decision
- QMCO Hold
- TCRX Strong Buy
- Analyst Count
- QMCO 2
- TCRX 6
- Target Price
- QMCO $19.00
- TCRX $9.50
- AVG Volume (30 Days)
- QMCO 2.8M
- TCRX 774.8K
- Earning Date
- QMCO 06-16-2025
- TCRX 05-06-2025
- Dividend Yield
- QMCO N/A
- TCRX N/A
- EPS Growth
- QMCO N/A
- TCRX N/A
- EPS
- QMCO N/A
- TCRX N/A
- Revenue
- QMCO $285,865,000.00
- TCRX $4,421,000.00
- Revenue This Year
- QMCO N/A
- TCRX $68.86
- Revenue Next Year
- QMCO $2.46
- TCRX $14.01
- P/E Ratio
- QMCO N/A
- TCRX N/A
- Revenue Growth
- QMCO N/A
- TCRX N/A
- 52 Week Low
- QMCO $2.22
- TCRX $1.02
- 52 Week High
- QMCO $90.64
- TCRX $9.29
- Technical
- Relative Strength Index (RSI)
- QMCO 47.42
- TCRX 52.31
- Support Level
- QMCO $11.06
- TCRX $1.39
- Resistance Level
- QMCO $14.29
- TCRX $1.49
- Average True Range (ATR)
- QMCO 1.56
- TCRX 0.11
- MACD
- QMCO 0.07
- TCRX 0.02
- Stochastic Oscillator
- QMCO 30.23
- TCRX 82.35
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.